 |
인쇄하기
취소
|
Huon’s fatty liver treatment in local phase-2 trials
Huons Co. said Monday it will begin phase-2 clinical trials of HL-09, a treatment for fatty liver, here in Korea.
The phase-2 trials are designed to evaluate the safety and efficacy of HL-09 (Magnolia Obovata Bark extract) in patients with fatty liver, the company said in its regulatory filing.
Magnolia bark has been used for treatment of gastrointestinal disorders, anxiety and allergic d...
The phase-2 trials are designed to evaluate the safety and efficacy of HL-09 (Magnolia Obovata Bark extract) in patients with fatty liver, the company said in its regulatory filing.
Magnolia bark has been used for treatment of gastrointestinal disorders, anxiety and allergic d...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.